- Determination of Rifaximin Treatment Period According to Lactulose Breath Test Values in Nonconstipated Irritable Bowel Syndrome Subjects
-
Bae S, Lee KJ, Kim YS, Kim KN
- KMID: 2160605
- J Korean Med Sci.
- 2015 Jun;30(6):757-762.
- doi: 10.3346/jkms.2015.30.6.757
Small intestinal bacterial overgrowth (SIBO) can partly explain irritable bowel syndrome (IBS), and rifaximin has been observed to improve abdominal symptoms in nonconstipated IBS patients. However, there are few reports... -
- CITED
-
- Close
- SHARE
-
- Close
